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Activation ofthe Respiratory Burst Oxidase
Bernard M. Babior
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California
The respiratory burst oxidase of phagocytes and B lymphocytes catalyzes the reduction of oxygen by NADPH to form O-, the precursor of a group
of reactive oxidants that are employed by phagocytes as microbicidal agents. The enzyme is active in stimulated cells but dormant in resting cells. It
is composed of several subunits: p22Phox, gp91 p47Phox p67Pho, and a low molecular weight guanine nucleotide-binding protein. The compo
nents p22Phox and gp9l phox form cytochrome b558, a flavohemoprotein that resides in the cortical cytoskeleton and in the membranes of the specific
granules. The other components are found in the cytosol of resting cells, but migrate to the cortical cytoskeleton when the neutrophils are activated,
where they assemble the active oxidase. Migration to the cortical cytoskeleton is caused in part by the appearance of a membrane binding site on
one or more of the cytosolic subunits, possibly due to the phosphorylation of p47phox that takes place during cell activation. - Environ Health
Perspect 102(Suppl 10):53-56 (1994)
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Introduction
The respiratory burst oxidase is a mem-
brane-bound enzyme found in phagocytes
and B lymphocytes (1). It catalyzes the
one-electron reduction of oxygen to °- at
the expense ofNADPH:
202+NADPH 20- + NADP+ + H+
Dormant in resting cells, the respiratory
burst oxidase is rapidly activated when the
cells are exposed to appropriate stimuli.
The role ofthe respiratory burst oxidase
in lymphocytes is obscure, though it might
be speculated that the 0- generated by
these cells is a signaling molecule, inas-
much as H202, which is rapidly produced
by the spontaneous dismutation of 01-
activates the expression of genes that are
under the control of the NF-KcB promoter
(2,3).
20 - )H2O2 +02
In phagocytes, however, the function ofthe
oxidase is clear. The 0° generated by this
enzyme is the precursor ofavariety ofpow-
erful oxidants used by these cells as micro-
bicidal agents. Included among these
oxidants are a variety ofoxidized halogens,
including hypohalite ions (4,5) and an
immense variety ofchloramines (6). These
are generated by the H202-mediated oxi-
dation of halide ions under catalysis by
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myeloperoxidase or eosinophil peroxidase
and the subsequent oxidation ofamines by
the product hypohalites:
peroxidase
H202 +X - HOX
+ OH [X = Cl-, Br-, IF]
HOX+ R-NH-R' - R-NX-R'
+ H20
Another group ofreactive oxidants that are
produced from 0- are the oxidizing radi-
cals (7,8), generated in a transition metal-
catalyzed reaction between 0- and a
hydroperoxide (this is the well-known
Haber-Weiss reaction, ifR = H),
0-+ROOH ) RO+OH 2 Fe or Cu
+ H20 [R = H, -C, -C(=O)]
or in a reaction between a previously gener-
ated oxidizing radical and another com-
pound:
OH, + RH R + H20
Finally, singlet oxygen has been found to
be produced by neutrophils and eosinophils
(9-11), possibly through a reaction between
hypohalite and H202:
HOX+H202 02+X-+H20
It is evident that the production of large
quantities ofoxidants with the reactivity of
the foregoing will generate an environment
that is lethal for any microorganism
exposed to it, but is at the same time highly
destructive to nearby tissues. It therefore
makes sense that the activity ofthis enzyme
is tightly regulated both spatially and tem-
porally, so that it releases its dangerous
product only under appropriate circum-
stances. As a concomitant feature of its
highly regulated nature, the enzyme is
structurally complex, composed of a num-
ber ofsubunits that are distributed between
two locations in resting cells but come
together to assemble the active oxidase
when the cell is stimulated. The following
section first describes the properties of the
components of the oxidase, followed by a
review of what is known about oxidase
activation at a molecular level.
The Components
In the resting cell, the components of the
respiratory burst oxidase are distributed
between the membrane and the cytosol.
Membrane-assodated Components
Membrane-associated components were
first discovered by two groups ofJapanese
workers some 30 years ago (12,13) and
were later connected to the respiratory
burst oxidase by experiments with neu-
trophils from patients with chronic granu-
lomatous disease (CGD), an inherited
disorder in which the respiratory burst oxi-
dase is missing or fails to function (14,15).
Purification and cloning disclosed two oxi-
dase-specific components, gp9lphox and
p22PhOx, that together formed a flavohemo-
protein known as cytochrome b558.
gp9jPho. This is a membrane-associ-
ated glycoprotein consisting of a 56-kDa
polypeptide that is glycosylated with several
high-mannose oligosaccharides that raise its
molecular weight to a value of approxi-
mately 90 kDa (16,17). It has five to six
transmembrane regions and a cytoplasmic
C-terminus, -PRGVHFIFNKENF, that
represents a docking site for a complex of
cytosolic subunits (18).
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p22PbOX. The other membrane-associ-
ated subunit is a simple protein with a sin-
gle transmembrane region (19,20). It
contains a sequence, -PPSNPPPRPP-,
that is highly homologous to the recently
discovered sequence of an SH3 domain-
binding region (21).
Cytochrome b558. Cytochrome b558 is
an electron-transporting component (some
think it is the electron-transporting com-
ponent) ofthe respiratory burst oxidase. It
is probably a trimer containing one
gp9lphox and two p22Phox subunits. It con-
tains two hemes shown by resonance
Raman spectroscopy to be in an unusual
environment and currently thought to be
shared between the three subunits (22). It
also appears to contain FAD (23-25).
This cytochrome has some characteris-
tic properties. Its redox potential is -245
mV, a very low value for heme proteins.
On optical spectroscopy, the oxidized
cytochrome shows a Soret peak at 428 nm
that increases in size and shifts to 413 nm
when the cytochrome is reduced. The
reduced cytochrome also shows a and ,
peaks at 558 and 528 nm, respectively.
Heme ligands such as CN, N-, CO, and
butyl isonitrile bind weakly or not at all. As
to the role of the cytochrome in electron
transport, it is generally held that the heme
is the terminal electron carrier, passing
electrons directly to oxygen, but this idea is
not supported by kinetic experiments,
which suggest that the rate ofreduction of
the heme is not compatible with an obliga-
tory role in electron transport.
Rap IA. RaplA is a low molecular
weight GTP-binding protein in neutrophil
membranes. A possible role for raplA in
the function of the respiratory burst oxi-
dase was suggested by the finding that
raplA copurified with cytochrome b558
(26). This protein, however, is found in
membranes from CGD neutrophils that
lack cytochrome b558, so it is not an intrin-
sic component ofthe cytochrome.
Components intheCytosol
p47Pho . The cytosolic protein p47Ph,, is
an oxidase component with a molecular
weight ofabout 45 kDa and apI of 10. It
contains a highly cationic C-terminal
region with several protein kinase A and
protein kinase C target sequences, and two
SH3 domains, a feature often seen in pro-
teins that associate with the actin cytoskele-
ton. During neutrophil activation, p47phox
becomes extensively phosphorylated on ser-
ine residues. It is likely that the phosphory-
lation of this protein has something to do
with the activation of the respiratory burst
oxidase, but unequivocal evidence estab-
lishing a cause-and-effect relationship
between these two events is not yet avail-
able.
p67PhOX. A second cytosolic component
isp67Phox, a protein of"65 kDa that is also
necessary for oxidase activity. Apart from
its two SH3 regions, p67PhoX has no distin-
guishing features, and its function in the
respiratory burst oxidase is not understood.
A Cytosolic Complex. When neutrophil
cytosol is subjected to gel filtration over
Superose 6, p47phoX and p67phox appear
together, both migrating with an Mr of
=240 K. Some P47phox also runs with an
Mr of "50 K, but all the p67Phox in the
cytosol is found in the =240 K peak. These
findings suggest that p47phox and p67phox
exist in the cytosol as a =240 K complex.
They further suggest that the quantity of
p47phox in the cytosol exceeds that of
p6phox
racl/rac2. It has been known for some
time that the respiratory burst oxidase
requires an active guanine nucleotide-bind-
ing protein (GN-binding protein) for its
operation. Thus GTP (or, better, a non-
hydrolyzable GTP analog such as GTPyS)
must be added to the cell-free oxidase-acti-
vating system to enable it to manufacture
O°. It has recently been shown that racl
and rac2 can fulfill the G-binding protein
requirement of the oxidase-activating sys-
tems from mouse macrophages and human
neutrophils, respectively (27,28). Further-
more, racl was isolated from mouse
macrophage cytosol as a complex with
rhoGDI, a protein that retards the activa-
tion of racl by preventing the dissociation
ofGDP from its active site, suggesting that
rhoGDI may participate in the mechanism
of activation of the respiratory burst oxi-
dase (28). On the other hand, it is not
clear which ofseveral GN-binding proteins
is the "right" one. At least three of these
proteins-racl, rac2, and the membrane-
associated protein raplA (29)-seem to
work in the cell-free oxidase activating sys-
tem, suggesting that any or all of them
might be the right GN-binding protein.
Moreover, there may be others yet to be
discovered that also work in the cell-free
oxidase activating system.
MechanismofActivation ofthe
RespiratoryBurstOxidase
The respiratory burst oxidase appears to be
activated by the assembly of its various
components into a catalytically functioning
enzyme in response to a stimulus.
Activation is associated with the transfer of
the p47phox/p67phox complex to the plasma
membrane. At a molecular level, there is
evidence that P47phox binds directly to the
membrane and that at least one ofthe sites
of interaction between the membrane and
the cytosolic complex consists ofthe 13 C-
terminal amino acid residues of gp91phox
(18), the larger of the two subunits that
make up cytochrome b558. The association
between the W47Phox/p67phox complex and
cytochrome b558 may be necessary to estab-
lish a complete electron transport chain
between NADPH and oxygen, because the
NADPH binding site seems to be associated
with a cytosolic component, while a flavin
required for oxidase activity is in the mem-
brane, probably bound to cytochrome b558.
In both resting and activated neutro-
phils, cytochrome b558 is associated with the
cytoskeleton (30, 31). In the activated neu-
trophil, the p47phox/p67phox complex also is
associated with the cytoskeleton (32), and
the O- -forming activity of the activated
plasma membranes is found in the
cytoskeletal fraction. The attachment ofthe
respiratory burst oxidase to the cytoskeleton
presumably serves to permit oxidase activa-
tion by a particulate stimulus (e.g., a
microorganism) to be restricted to the area
ofmembrane in contact with the particle.
Cross-linking experiments suggest that
the transfer of the p47Phox/p67phox com-
plex to the plasma membrane results from
a change in the structure of the complex
that creates a membrane-binding site upon
oxidase activation (33). When neutrophil
cytosol was briefly exposed to a 3,3'-
dithiobis(sulfosuccinimidylpropionate)
(DTSSP), a cleavable cross-linking agent, it
lost a substantial fraction of its ability to
support 0° production by the cell-free oxi-
dase activating system in response to SDS.
Much of this activity was restored, how-
ever, when the DTSSP was cleaved with
mercaptoethanol. Control cytosols treated
with the noncleavable cross-linker bis(sul-
fosuccinimidyl)suberate (BS3) also lost
much of their 01 -generating activity in
the cell-free system, but mercaptoethanol
had no effect on the BS3-treated cytosol.
DTSSP treatment greatly inhibited the
SDS-induced transfer ofP47phox from neu-
trophil cytosol to the plasma membrane in
the cell-free system, but transfer was partly
restored when the cross-linked cytosol was
treated with mercaptoethanol. It was con-
cluded from these results that some sort of
structural alteration in the cytosolic oxidase
components was necessary for oxidase acti-
vation to take place. Gel filtration experi-
ments indicated that this structural change
did not involve a major alteration in the
molecular weight of the p47Phox/p67phox
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complex, but a small change in molecular
weight could not be ruled out. Alternatively,
the structural change might just involve a
conformational alteration in one or more
ofthe cytosolic oxidase components.
This structural change could be related
to the phosphorylation of p47phox that
takes place when the respiratory burst oxi-
dase is activated in whole cells (34,35).
During the activation ofthe oxidase, seven
to eight of the serines in P47phOX become
phosphorylated. The phosphorylation of
these serine residues occurs in two stages
(35-37). During the first stage, which
takes place in the cytosol, most of the
phosphates are introduced into the protein.
At the end ofthe first stage ofphosphoryla-
tion, the p47Pho,/p67Phox complex moves
from the cytosol to the plasma membrane,
where it associates with cytochrome b558.
The second stage of phosphorylation then
takes place, resulting in the transfer of the
final one or two phosphate residues to
p47phox. It is possible that the phosphoryla-
tion ofp47phox activates the oxidase in vivo
by inducing a conformational change simi-
lar to the SDS-induced conformational
change that creates the membrane-binding
site on the p47phox1p67phox complex and
activates the oxidase in the cell-free system.
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